Oxford Textbook of Osteoarthritis and Crystal Arthropathy, Third Edition
Herausgeber: Doherty, Michael; Dalbeth, Nicola; Hunter, David; Arden, Nigel; Bijlsma, Hans
Oxford Textbook of Osteoarthritis and Crystal Arthropathy, Third Edition
Herausgeber: Doherty, Michael; Dalbeth, Nicola; Hunter, David; Arden, Nigel; Bijlsma, Hans
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Now extensively revised and in its third edition, this Oxford Textbook is the definitive guide to the most common forms of arthritis. A practical resource for clinicians working with forms of crystal associated arthritis, it provides comprehensive guidance on how to assess, diagnose and optimally manage patients with these conditions
Andere Kunden interessierten sich auch für
- Oxford Textbook of Psoriatic Arthritis176,99 €
- Oxford Textbook of Sjögren's Syndrome194,99 €
- Oxford Textbook of Axial Spondyloarthritis242,99 €
- Oxford Textbook of Rheumatoid Arthritis193,99 €
- Binita R ShahAtlas of Pediatric Emergency Medicine, Third Edition253,99 €
- Michael A. Becker / Ralph H. Schumacher / Robert L. Wortmann (eds.)Crystal-Induced Arthropathies274,99 €
- Ray L. WattsMovement Disorders, Third Edition323,99 €
-
-
-
Now extensively revised and in its third edition, this Oxford Textbook is the definitive guide to the most common forms of arthritis. A practical resource for clinicians working with forms of crystal associated arthritis, it provides comprehensive guidance on how to assess, diagnose and optimally manage patients with these conditions
Produktdetails
- Produktdetails
- Verlag: Oxford University Press, USA
- 3rd edition
- Seitenzahl: 522
- Erscheinungstermin: 1. Dezember 2016
- Englisch
- Abmessung: 282mm x 226mm x 25mm
- Gewicht: 1542g
- ISBN-13: 9780199668847
- ISBN-10: 0199668841
- Artikelnr.: 47869483
- Verlag: Oxford University Press, USA
- 3rd edition
- Seitenzahl: 522
- Erscheinungstermin: 1. Dezember 2016
- Englisch
- Abmessung: 282mm x 226mm x 25mm
- Gewicht: 1542g
- ISBN-13: 9780199668847
- ISBN-10: 0199668841
- Artikelnr.: 47869483
Professor Michael Doherty MA MD FRCP FHEA is Professor of Rheumatology and Head of Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham. His main research interests are osteoarthritis (OA), gout, calcium pyrophosphate crystal deposition (CPPD), placebo/contextual response and evidence based medicine. He has expertise in clinical and epidemiological studies, community-based clinical trials, systematic reviews and meta-analyses. He has over 300 original research publications and was awarded the OA Research Society International (OARSI) Clinical Research Award for 2012. He is a past editor of Annals of the Rheumatic Diseases (1992-99), has co-chaired EULAR Task Forces for recommendations for OA, gout and CPPD arthritis, and has been involved as a clinical expert in NICE appraisals for OA and gout. Professor David Hunter is a rheumatology clinician researcher whose main research focus has been clinical and translational research in osteoarthritis (OA). He is the Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney, and Staff Specialist at Royal North Shore Hospital and North Sydney Orthopaedic and Sports Medicine Centre. His research is focused on a number of key elements in OA including (but not limited to) the epidemiology of osteoarthritis, the application of imaging to better understand structure and function with application to both epidemiologic research and clinical trials, novel therapies in disease management and heath service system delivery of chronic disease management. He is an editor for leading international journals in his field. He has authored books on osteoarthritis and has over 350 publications in peer reviewed journals. Johannes (Hans) Bijlsma is professor of Rheumatology at the University of Utrecht, as well as at both Universities (VU and UVA) in Amsterdam. He was Head of the Department of Rheumatology and Immunology in Utrecht (1989-2013) and of the Amsterdam Rheumatology and immunology Center (2013-2015). His main research interests are osteoarthritis (OA), treatment strategies in rheumatoid arthritis and glucocorticoids. He has expertise in clinical and epidemiological studies, randomised controlled clinical trials in early RA, systematic reviews and meta-analyses. He has over 600 original research publications and was awarded the Jan van Breemen Award for his scientific work in the Netherlands (2015). He is an associate editor of Annals of the Rheumatic Diseases (2005 - ongoing), has co-chaired EULAR Task Forces for recommendations for OA and the use of glucocorticoids. He has been the chair of Education of EULAR, the coordinator of the EULAR online courses and is presently the President-elect of EULAR Nigel Arden is a Professor of Rheumatic Diseases and an International Leader in Epidemiology and predictive modelling and trial design. He has clinical and research expertise in osteoarthritis, arthroplasty and osteoporosis and has published numerous manuscripts based on the use of cohort and large routinely collected databases in musculoskeletal diseases and their treatment. His research interests focus on the epidemiology of musculoskeletal diseases, with a focus on Osteoarthritis and Osteoporosis. He is based in the Botnar Research Centre, University of Oxford with additional sessions at the MRC Lifecourse Epidemiology Unit at the University of Southampton. Professor Nicola Dalbeth is an academic rheumatologist who leads a clinical and laboratory programme of research in gout, an inflammatory arthritis of major significance to Aotearoa New Zealand. Her work focuses on understanding the impact and mechanisms of disease in gout. She is a founding member of the Counties Manukau District Health Board Maori Gout Action Group, and she was the Lead Clinical Advisor for the Gout Clinical Pathways (Greater Auckland Integrated Healthcare Network) and the national bpac Gout Treatment Guidelines. She has served as an Expert Panel member on the American College of Rheumatology Gout Management Guidelines, and is a steering committee member for the OMERACT gout working group and the ACR/EULAR gout classification project.
* 1. What is Osteoarthritis?
* 1: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth and
David Hunter: What is Osteoarthritis?
* 2: Juliet Rogers and Paul Dieppe: Paleopathology
* 3: Laura A. Stoppiello and Michael Doherty: Morphological aspects of
pathology
* 2. Tissues
* 4: Peter M van der Kraan and Esmeralda N Blaney Davidson: Cartilage
* 5: Steven R. Goldring and Richard L. Menschel: Pathophysiology of
peri-articular bone changes in osteoarthritis
* 6: Floris Lafeber, N.J. Besselink and S.C. Mastbergen:
Osteoarthritis: synovium and capsule
* 7: Jason J. McDougall and Joel A. Vilensky: Neuromuscular
* 3. Epidemiology
* 8: Nigel Arden and Michael C. Nevitt: Epidemiology
* 4. Risk factors
* 9: Ana M Valdes: Genetics
* 10: Joanne M. Jordan, Kelli D. Allen and Leigh F. Callahan: Age,
gender, race/ethnicity, and socioeconomic status in osteoarthritis
and its outcomes
* 11: Richard Aspden and Jenny Gregory: Morphology
* 12: J. Runhaar and S.M.A. Bierma-Zeinstra: Lifestyle
* 5. Pain
* 13: Philip Mease: Neurobiology of pain in osteoarthritis
* 14: David A Walsh: Contextual aspects of pain; why does the patient
hurt?
* 6. Clinical assessment
* 15: Margreet Kloppenburg: Clinical assessment: signs, symptoms and
patient perceptions in osteoarthritis
* 16: Daichi Hayashi, Ali Guermazi and Frank W. Roemer: Radiography and
Computed Tomography Imaging of Osteoarthritis
* 17: Walter Grassi, Tadashi Okano and Emilio Filippucci: Ultrasound in
osteoarthritis and crystal-related arthropathies
* 18: David Hunter and Frank Roemer: Imaging - MRI
* 19: Leticia Alle Deveza, Changhai Ding, Xingzhong Jin, Xia Wang,
Zhaohua Zhu and David Hunter: Laboratory tests
* 7. Management
* 20: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth
and David J. Hunter: Introduction: the comprehensive approach
* 21: Gillian Hawker, Anne Lyddiatt, Linda Li, Dawn Stacey, Susan
Jaglal, Sarah Munce and Esther Waugh: Patient information strategies
for decision making and management of osteoarthritis
* 22: Kim L Bennell, Ans Van Ginckel, Fiona Dobson and Rana S Hinman:
Exercise for the person with osteoarthritis
* 23: Marius Henriksen, Robin Christensen, Berit L. Heitmann and
Henning Bliddal: Weight loss
* 24: Christelle Nguyen and François Rannou: Addressing adverse
mechanical factors
* 25: Joost Dekker, Daniel Bossen, Jasmijn Holla, Mariëtte de Rooij,
Cindy Veenhof and Marike van der Leeden: Psychological strategies in
osteoarthritis of the knee or hip
* 26: MA Holden, MJ Thomas and KS Dziedzic: Miscellaneous Physical
Therapies
* 27: Dr. A. Abhishek and Prof. M. Doherty,: Placebo, nocebo and
contextual effects
* 8. Pharmacological therapies
* 28: Dr A Abhishek, Dr Adrian Jones and Professor Michael Doherty:
Topical pharmacologic treatments
* 29: Bernard Bannwarth and Francis Berenbaum: Systemic analgesics
(including paracetamol and opioids)
* 30: Lee S. Simon and Marc C. Hochberg: Non-steroidal
anti-inflammatory drugs
* 31: Allen D Sawitzke and Daniel O Clegg: Supplements for the
treatment of Osteoarthritis
* 32: Nigel Arden and Terence O'Neill: Intra-articular injection
therapy
* 9. Surgery
* 33: Andrew Price, Paul Monk and David Beard: Arthoplasty and its
complications
* 34: Jonas Bloch Thorlund and L. Stefan Lohmander: Other surgical
approaches in the management of osteoarthritis
* 10. Prospects for disease modification
* 35: Shirley Pei-Chun Yu and David John Hunter: Prospects for disease
modification
* 11. Delivery of care
* 36: Caroline A Brand and Ilana N Ackerman: Delivery (organisation and
outcome)
* 12. Guidelines
* 37: Weiya Zhang and Michael Doherty: Guidelines
* 13. Gout
* 38: Samantha Hider and Edward Roddy: Epidemiology of gout
* 39: Nicola Dalbeth: Pathophysiology of gout
* 40: Tony R Merriman: The genetic basis of gout
* 41: Tim L Jansen: Clinical presentation of gout
* 42: Eliseo Pascual and Francisca Sivera: Laboratory investigations in
gout
* 43: Robert T. Keenan, Sneha Pai and Naomi Schlesinger: Imaging of
gout
* 44: Pascal Richette: Principles of gout management
* 45: Puja Khanna: Treatment of acute gout
* 46: Fernando Perez-Ruiz, Irati Urionaguena and Sandra P. Chinchilla:
Long-term management of gout
* 47: Thomas Bardin: Asymptomatic hyperuricaemia - to treat or not to
treat?
* 14. Calcium pyrophosphate crystal deposition
* 48: Dr A Abhishek and Professor Michael Doherty: Epidemiology and
risk factors for calcium pyrophosphate deposition
* 49: Dr A Abhishek and Professor Michael Doherty: Pathophysiology of
calcium pyrophosphate deposition
* 50: Dr A Abhishek and Professor Michael Doherty: Clinical features of
calcium pyrophosphate crystal deposition
* 51: Dr A Abhishek and Professor Michael Doherty: Investigations of
calcium pyrophosphate deposition
* 52: Dr A Abhishek and Professor Michael Doherty: Treatment of calcium
pyrophosphate deposition
* 15. Basic calcium phosphates
* 53: Nicola Dalbeth: Basic calcium phosphates and osteoarthritis
* 1: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth and
David Hunter: What is Osteoarthritis?
* 2: Juliet Rogers and Paul Dieppe: Paleopathology
* 3: Laura A. Stoppiello and Michael Doherty: Morphological aspects of
pathology
* 2. Tissues
* 4: Peter M van der Kraan and Esmeralda N Blaney Davidson: Cartilage
* 5: Steven R. Goldring and Richard L. Menschel: Pathophysiology of
peri-articular bone changes in osteoarthritis
* 6: Floris Lafeber, N.J. Besselink and S.C. Mastbergen:
Osteoarthritis: synovium and capsule
* 7: Jason J. McDougall and Joel A. Vilensky: Neuromuscular
* 3. Epidemiology
* 8: Nigel Arden and Michael C. Nevitt: Epidemiology
* 4. Risk factors
* 9: Ana M Valdes: Genetics
* 10: Joanne M. Jordan, Kelli D. Allen and Leigh F. Callahan: Age,
gender, race/ethnicity, and socioeconomic status in osteoarthritis
and its outcomes
* 11: Richard Aspden and Jenny Gregory: Morphology
* 12: J. Runhaar and S.M.A. Bierma-Zeinstra: Lifestyle
* 5. Pain
* 13: Philip Mease: Neurobiology of pain in osteoarthritis
* 14: David A Walsh: Contextual aspects of pain; why does the patient
hurt?
* 6. Clinical assessment
* 15: Margreet Kloppenburg: Clinical assessment: signs, symptoms and
patient perceptions in osteoarthritis
* 16: Daichi Hayashi, Ali Guermazi and Frank W. Roemer: Radiography and
Computed Tomography Imaging of Osteoarthritis
* 17: Walter Grassi, Tadashi Okano and Emilio Filippucci: Ultrasound in
osteoarthritis and crystal-related arthropathies
* 18: David Hunter and Frank Roemer: Imaging - MRI
* 19: Leticia Alle Deveza, Changhai Ding, Xingzhong Jin, Xia Wang,
Zhaohua Zhu and David Hunter: Laboratory tests
* 7. Management
* 20: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth
and David J. Hunter: Introduction: the comprehensive approach
* 21: Gillian Hawker, Anne Lyddiatt, Linda Li, Dawn Stacey, Susan
Jaglal, Sarah Munce and Esther Waugh: Patient information strategies
for decision making and management of osteoarthritis
* 22: Kim L Bennell, Ans Van Ginckel, Fiona Dobson and Rana S Hinman:
Exercise for the person with osteoarthritis
* 23: Marius Henriksen, Robin Christensen, Berit L. Heitmann and
Henning Bliddal: Weight loss
* 24: Christelle Nguyen and François Rannou: Addressing adverse
mechanical factors
* 25: Joost Dekker, Daniel Bossen, Jasmijn Holla, Mariëtte de Rooij,
Cindy Veenhof and Marike van der Leeden: Psychological strategies in
osteoarthritis of the knee or hip
* 26: MA Holden, MJ Thomas and KS Dziedzic: Miscellaneous Physical
Therapies
* 27: Dr. A. Abhishek and Prof. M. Doherty,: Placebo, nocebo and
contextual effects
* 8. Pharmacological therapies
* 28: Dr A Abhishek, Dr Adrian Jones and Professor Michael Doherty:
Topical pharmacologic treatments
* 29: Bernard Bannwarth and Francis Berenbaum: Systemic analgesics
(including paracetamol and opioids)
* 30: Lee S. Simon and Marc C. Hochberg: Non-steroidal
anti-inflammatory drugs
* 31: Allen D Sawitzke and Daniel O Clegg: Supplements for the
treatment of Osteoarthritis
* 32: Nigel Arden and Terence O'Neill: Intra-articular injection
therapy
* 9. Surgery
* 33: Andrew Price, Paul Monk and David Beard: Arthoplasty and its
complications
* 34: Jonas Bloch Thorlund and L. Stefan Lohmander: Other surgical
approaches in the management of osteoarthritis
* 10. Prospects for disease modification
* 35: Shirley Pei-Chun Yu and David John Hunter: Prospects for disease
modification
* 11. Delivery of care
* 36: Caroline A Brand and Ilana N Ackerman: Delivery (organisation and
outcome)
* 12. Guidelines
* 37: Weiya Zhang and Michael Doherty: Guidelines
* 13. Gout
* 38: Samantha Hider and Edward Roddy: Epidemiology of gout
* 39: Nicola Dalbeth: Pathophysiology of gout
* 40: Tony R Merriman: The genetic basis of gout
* 41: Tim L Jansen: Clinical presentation of gout
* 42: Eliseo Pascual and Francisca Sivera: Laboratory investigations in
gout
* 43: Robert T. Keenan, Sneha Pai and Naomi Schlesinger: Imaging of
gout
* 44: Pascal Richette: Principles of gout management
* 45: Puja Khanna: Treatment of acute gout
* 46: Fernando Perez-Ruiz, Irati Urionaguena and Sandra P. Chinchilla:
Long-term management of gout
* 47: Thomas Bardin: Asymptomatic hyperuricaemia - to treat or not to
treat?
* 14. Calcium pyrophosphate crystal deposition
* 48: Dr A Abhishek and Professor Michael Doherty: Epidemiology and
risk factors for calcium pyrophosphate deposition
* 49: Dr A Abhishek and Professor Michael Doherty: Pathophysiology of
calcium pyrophosphate deposition
* 50: Dr A Abhishek and Professor Michael Doherty: Clinical features of
calcium pyrophosphate crystal deposition
* 51: Dr A Abhishek and Professor Michael Doherty: Investigations of
calcium pyrophosphate deposition
* 52: Dr A Abhishek and Professor Michael Doherty: Treatment of calcium
pyrophosphate deposition
* 15. Basic calcium phosphates
* 53: Nicola Dalbeth: Basic calcium phosphates and osteoarthritis
* 1. What is Osteoarthritis?
* 1: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth and
David Hunter: What is Osteoarthritis?
* 2: Juliet Rogers and Paul Dieppe: Paleopathology
* 3: Laura A. Stoppiello and Michael Doherty: Morphological aspects of
pathology
* 2. Tissues
* 4: Peter M van der Kraan and Esmeralda N Blaney Davidson: Cartilage
* 5: Steven R. Goldring and Richard L. Menschel: Pathophysiology of
peri-articular bone changes in osteoarthritis
* 6: Floris Lafeber, N.J. Besselink and S.C. Mastbergen:
Osteoarthritis: synovium and capsule
* 7: Jason J. McDougall and Joel A. Vilensky: Neuromuscular
* 3. Epidemiology
* 8: Nigel Arden and Michael C. Nevitt: Epidemiology
* 4. Risk factors
* 9: Ana M Valdes: Genetics
* 10: Joanne M. Jordan, Kelli D. Allen and Leigh F. Callahan: Age,
gender, race/ethnicity, and socioeconomic status in osteoarthritis
and its outcomes
* 11: Richard Aspden and Jenny Gregory: Morphology
* 12: J. Runhaar and S.M.A. Bierma-Zeinstra: Lifestyle
* 5. Pain
* 13: Philip Mease: Neurobiology of pain in osteoarthritis
* 14: David A Walsh: Contextual aspects of pain; why does the patient
hurt?
* 6. Clinical assessment
* 15: Margreet Kloppenburg: Clinical assessment: signs, symptoms and
patient perceptions in osteoarthritis
* 16: Daichi Hayashi, Ali Guermazi and Frank W. Roemer: Radiography and
Computed Tomography Imaging of Osteoarthritis
* 17: Walter Grassi, Tadashi Okano and Emilio Filippucci: Ultrasound in
osteoarthritis and crystal-related arthropathies
* 18: David Hunter and Frank Roemer: Imaging - MRI
* 19: Leticia Alle Deveza, Changhai Ding, Xingzhong Jin, Xia Wang,
Zhaohua Zhu and David Hunter: Laboratory tests
* 7. Management
* 20: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth
and David J. Hunter: Introduction: the comprehensive approach
* 21: Gillian Hawker, Anne Lyddiatt, Linda Li, Dawn Stacey, Susan
Jaglal, Sarah Munce and Esther Waugh: Patient information strategies
for decision making and management of osteoarthritis
* 22: Kim L Bennell, Ans Van Ginckel, Fiona Dobson and Rana S Hinman:
Exercise for the person with osteoarthritis
* 23: Marius Henriksen, Robin Christensen, Berit L. Heitmann and
Henning Bliddal: Weight loss
* 24: Christelle Nguyen and François Rannou: Addressing adverse
mechanical factors
* 25: Joost Dekker, Daniel Bossen, Jasmijn Holla, Mariëtte de Rooij,
Cindy Veenhof and Marike van der Leeden: Psychological strategies in
osteoarthritis of the knee or hip
* 26: MA Holden, MJ Thomas and KS Dziedzic: Miscellaneous Physical
Therapies
* 27: Dr. A. Abhishek and Prof. M. Doherty,: Placebo, nocebo and
contextual effects
* 8. Pharmacological therapies
* 28: Dr A Abhishek, Dr Adrian Jones and Professor Michael Doherty:
Topical pharmacologic treatments
* 29: Bernard Bannwarth and Francis Berenbaum: Systemic analgesics
(including paracetamol and opioids)
* 30: Lee S. Simon and Marc C. Hochberg: Non-steroidal
anti-inflammatory drugs
* 31: Allen D Sawitzke and Daniel O Clegg: Supplements for the
treatment of Osteoarthritis
* 32: Nigel Arden and Terence O'Neill: Intra-articular injection
therapy
* 9. Surgery
* 33: Andrew Price, Paul Monk and David Beard: Arthoplasty and its
complications
* 34: Jonas Bloch Thorlund and L. Stefan Lohmander: Other surgical
approaches in the management of osteoarthritis
* 10. Prospects for disease modification
* 35: Shirley Pei-Chun Yu and David John Hunter: Prospects for disease
modification
* 11. Delivery of care
* 36: Caroline A Brand and Ilana N Ackerman: Delivery (organisation and
outcome)
* 12. Guidelines
* 37: Weiya Zhang and Michael Doherty: Guidelines
* 13. Gout
* 38: Samantha Hider and Edward Roddy: Epidemiology of gout
* 39: Nicola Dalbeth: Pathophysiology of gout
* 40: Tony R Merriman: The genetic basis of gout
* 41: Tim L Jansen: Clinical presentation of gout
* 42: Eliseo Pascual and Francisca Sivera: Laboratory investigations in
gout
* 43: Robert T. Keenan, Sneha Pai and Naomi Schlesinger: Imaging of
gout
* 44: Pascal Richette: Principles of gout management
* 45: Puja Khanna: Treatment of acute gout
* 46: Fernando Perez-Ruiz, Irati Urionaguena and Sandra P. Chinchilla:
Long-term management of gout
* 47: Thomas Bardin: Asymptomatic hyperuricaemia - to treat or not to
treat?
* 14. Calcium pyrophosphate crystal deposition
* 48: Dr A Abhishek and Professor Michael Doherty: Epidemiology and
risk factors for calcium pyrophosphate deposition
* 49: Dr A Abhishek and Professor Michael Doherty: Pathophysiology of
calcium pyrophosphate deposition
* 50: Dr A Abhishek and Professor Michael Doherty: Clinical features of
calcium pyrophosphate crystal deposition
* 51: Dr A Abhishek and Professor Michael Doherty: Investigations of
calcium pyrophosphate deposition
* 52: Dr A Abhishek and Professor Michael Doherty: Treatment of calcium
pyrophosphate deposition
* 15. Basic calcium phosphates
* 53: Nicola Dalbeth: Basic calcium phosphates and osteoarthritis
* 1: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth and
David Hunter: What is Osteoarthritis?
* 2: Juliet Rogers and Paul Dieppe: Paleopathology
* 3: Laura A. Stoppiello and Michael Doherty: Morphological aspects of
pathology
* 2. Tissues
* 4: Peter M van der Kraan and Esmeralda N Blaney Davidson: Cartilage
* 5: Steven R. Goldring and Richard L. Menschel: Pathophysiology of
peri-articular bone changes in osteoarthritis
* 6: Floris Lafeber, N.J. Besselink and S.C. Mastbergen:
Osteoarthritis: synovium and capsule
* 7: Jason J. McDougall and Joel A. Vilensky: Neuromuscular
* 3. Epidemiology
* 8: Nigel Arden and Michael C. Nevitt: Epidemiology
* 4. Risk factors
* 9: Ana M Valdes: Genetics
* 10: Joanne M. Jordan, Kelli D. Allen and Leigh F. Callahan: Age,
gender, race/ethnicity, and socioeconomic status in osteoarthritis
and its outcomes
* 11: Richard Aspden and Jenny Gregory: Morphology
* 12: J. Runhaar and S.M.A. Bierma-Zeinstra: Lifestyle
* 5. Pain
* 13: Philip Mease: Neurobiology of pain in osteoarthritis
* 14: David A Walsh: Contextual aspects of pain; why does the patient
hurt?
* 6. Clinical assessment
* 15: Margreet Kloppenburg: Clinical assessment: signs, symptoms and
patient perceptions in osteoarthritis
* 16: Daichi Hayashi, Ali Guermazi and Frank W. Roemer: Radiography and
Computed Tomography Imaging of Osteoarthritis
* 17: Walter Grassi, Tadashi Okano and Emilio Filippucci: Ultrasound in
osteoarthritis and crystal-related arthropathies
* 18: David Hunter and Frank Roemer: Imaging - MRI
* 19: Leticia Alle Deveza, Changhai Ding, Xingzhong Jin, Xia Wang,
Zhaohua Zhu and David Hunter: Laboratory tests
* 7. Management
* 20: Michael Doherty, Nigel Arden, Johannes Bijlsma, Nicola Dalbeth
and David J. Hunter: Introduction: the comprehensive approach
* 21: Gillian Hawker, Anne Lyddiatt, Linda Li, Dawn Stacey, Susan
Jaglal, Sarah Munce and Esther Waugh: Patient information strategies
for decision making and management of osteoarthritis
* 22: Kim L Bennell, Ans Van Ginckel, Fiona Dobson and Rana S Hinman:
Exercise for the person with osteoarthritis
* 23: Marius Henriksen, Robin Christensen, Berit L. Heitmann and
Henning Bliddal: Weight loss
* 24: Christelle Nguyen and François Rannou: Addressing adverse
mechanical factors
* 25: Joost Dekker, Daniel Bossen, Jasmijn Holla, Mariëtte de Rooij,
Cindy Veenhof and Marike van der Leeden: Psychological strategies in
osteoarthritis of the knee or hip
* 26: MA Holden, MJ Thomas and KS Dziedzic: Miscellaneous Physical
Therapies
* 27: Dr. A. Abhishek and Prof. M. Doherty,: Placebo, nocebo and
contextual effects
* 8. Pharmacological therapies
* 28: Dr A Abhishek, Dr Adrian Jones and Professor Michael Doherty:
Topical pharmacologic treatments
* 29: Bernard Bannwarth and Francis Berenbaum: Systemic analgesics
(including paracetamol and opioids)
* 30: Lee S. Simon and Marc C. Hochberg: Non-steroidal
anti-inflammatory drugs
* 31: Allen D Sawitzke and Daniel O Clegg: Supplements for the
treatment of Osteoarthritis
* 32: Nigel Arden and Terence O'Neill: Intra-articular injection
therapy
* 9. Surgery
* 33: Andrew Price, Paul Monk and David Beard: Arthoplasty and its
complications
* 34: Jonas Bloch Thorlund and L. Stefan Lohmander: Other surgical
approaches in the management of osteoarthritis
* 10. Prospects for disease modification
* 35: Shirley Pei-Chun Yu and David John Hunter: Prospects for disease
modification
* 11. Delivery of care
* 36: Caroline A Brand and Ilana N Ackerman: Delivery (organisation and
outcome)
* 12. Guidelines
* 37: Weiya Zhang and Michael Doherty: Guidelines
* 13. Gout
* 38: Samantha Hider and Edward Roddy: Epidemiology of gout
* 39: Nicola Dalbeth: Pathophysiology of gout
* 40: Tony R Merriman: The genetic basis of gout
* 41: Tim L Jansen: Clinical presentation of gout
* 42: Eliseo Pascual and Francisca Sivera: Laboratory investigations in
gout
* 43: Robert T. Keenan, Sneha Pai and Naomi Schlesinger: Imaging of
gout
* 44: Pascal Richette: Principles of gout management
* 45: Puja Khanna: Treatment of acute gout
* 46: Fernando Perez-Ruiz, Irati Urionaguena and Sandra P. Chinchilla:
Long-term management of gout
* 47: Thomas Bardin: Asymptomatic hyperuricaemia - to treat or not to
treat?
* 14. Calcium pyrophosphate crystal deposition
* 48: Dr A Abhishek and Professor Michael Doherty: Epidemiology and
risk factors for calcium pyrophosphate deposition
* 49: Dr A Abhishek and Professor Michael Doherty: Pathophysiology of
calcium pyrophosphate deposition
* 50: Dr A Abhishek and Professor Michael Doherty: Clinical features of
calcium pyrophosphate crystal deposition
* 51: Dr A Abhishek and Professor Michael Doherty: Investigations of
calcium pyrophosphate deposition
* 52: Dr A Abhishek and Professor Michael Doherty: Treatment of calcium
pyrophosphate deposition
* 15. Basic calcium phosphates
* 53: Nicola Dalbeth: Basic calcium phosphates and osteoarthritis